ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1908

Quality Of Life and Adherence To Treatment In Patients Managed In Nursing Clinics In Rheumatology

Santiago Muñoz-Fernández1, Pablo Lazaro2, Antonio Javier Blasco3, Sandra Fortea Gracia4, Laura Cano-García5, Jose A. Roman Ivorra6, Raquel Almodóvar González7, José Santos Rey Rey8, Teresa Navío-Marco9 and Mercedes Cabañas3, 1Rheumatology, Hospital Infanta Sofía. San Sebastián de los Reyes. Spain, Madrid, Spain, 2Research, Advanced Techniques in Health Services Research (TAISS), Madrid, Spain, 3Advanced Techniques in Health Services Research (TAISS), Madrid, Spain, 4Servicio de Reumatología, Hospital de Sagunto, Sagunto, Spain, 5Hospital Regional Universitario Carlos Haya, Málaga, Spain, 6Servicio de ReumatologIa, Hospital Universitario y Politécnico La Fe, Valencia, Spain, 7Rheumatology Unit, Hospital Universitario Fundación Alcorcón, Madrid, Spain, 8Servicio de Reumatología, Complejo Hospitalario de Toledo, Toledo, Spain, 9Department of Rheumatology, Hospital Universitario Infanta Leonor, Madrid, Spain

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Compliance, nursing roles and quality of life

  • Tweet
  • Email
  • Print
Session Information

Title: Health Services Research, Quality Measures and Quality of Care - Innovations in Health Care Delivery

Session Type: Abstract Submissions (ACR)

Background/Purpose: Nursing clinics in rheumatology (NCR) are organizational models in the field of nursing care. However, little is known about the NCR outcomes. The purpose of this research is to evaluate differences between centers with and without NCR in patients’ quality of life and treatment adherence.

 Methods: Cross-sectional study carried out in rheumatology departments of 39 Spanish public hospitals from July to December 2012. The minimum requisites that the department must have to be defined as NCR were: 1) A nursing office, but not necessarily every day of the week; 2) at least one specialist nurse, at full or part time; 3) nurse appointment book; and 4) a dedicated telephone. Patients inclusion criteria were: 1) older than 18 years; 2) diagnosed of rheumatoid arthritis (RA) or ankylosing spondylitis (AS); 3) treated with at least one DMARD or a biologic; and 4) signing the informed consent. Data were collected through a survey with case report forms (CRF) completed by rheumatologists and patients. Sociodemographic, disease characteristics, treatment, quality of life and adherence variables were collected. The EuroQol-5D (EQ-5D) and Morisky-Green test were used to assess the quality of life and adherence to treatment, respectively. Regional and hospitals research and ethics committees approved the project protocol and CRFs.

 Results: Twenty one centers were NCR and 18 were no-NCR. The NCR centers included 181 patients (142 RA and 39 AS) and the no-NCR centers included 212 patients (160 RA and 52 AS). There were no statistically significant differences between NCR and no-NCR patients in: age [mean±SD, years] (53.2±11.8 vs. 56.3±13.5), gender [male, %] (29.8 vs. 38.7), rheumatic disease [RA, %] (78.5 vs. 75.5), years diagnosed (10.6±8.8 vs. 9.5±8.9), treatment [only biologics, only DMARDs, both %] (23.8, 39.2, 37.0 vs. 23.6, 46.7, 29.7, respectively), DAS-28 (2.87±1.28 vs. 2.97±1.19) and HAQ (0.81±0.68 vs. 0.88±0.68) in patients with RA, and BASDAI (3.44±2.41 vs. 3.68±2.31) and BASFI (3.15±2.78 vs. 3.85±2.60) in patients with AS. No statistical differences were observed between NCR and no-NCR in EQ-5D index (0.68±0.21 vs. 0.66±0.21) and EQ-5D Visual Analogue Scale (64.6±21.0 vs. 64.5±20.5). Patients from NCR have a better adherence to treatment than the no-NCR patients [adherent patients, %] (79.0 vs. 69.3; p=0.03).

 Conclusion: Patients managed in rheumatology departments with NCR have clinical characteristics, treatment patterns and quality of life similar to patients managed in centers without NCR, however, they have better adherence to treatment.


Disclosure:

S. Muñoz-Fernández,

AbbVie,

2,

BMS.,

5,

AbbVie,

5,

MSD,

5;

P. Lazaro,
None;

A. J. Blasco,
None;

S. Fortea Gracia,
None;

L. Cano-García,
None;

J. A. Roman Ivorra,

UCB,

2,

Pfizer Inc,

2,

Roche Pharmaceuticals,

2,

MSD,

2,

Actelion ,

5,

Bristol-Myers Squibb,

5,

AbbVie,

5,

Pfizer Inc,

5;

R. Almodóvar González,
None;

J. S. Rey Rey,
None;

T. Navío-Marco,
None;

M. Cabañas,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/quality-of-life-and-adherence-to-treatment-in-patients-managed-in-nursing-clinics-in-rheumatology/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology